Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05642026

INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures

Conditions: Rib Fractures

Sex: All
Ages: 18 Years – N/A
Phase: PHASE4
Enrollment: 180
Sponsor: Zachary Warriner

Location: United States

Summary

This is a prospective, randomized, non-blinded study comparing CINB plus medical therapy versus standard medical care (non-steroidals and opioids intravenous/oral inpatient and oral outpatient) alone for patients with multiple rib fractures. The objective of this study is to analyze the effect of continuous intercostal nerve block (CINB) in the treatment of patients admitted to the adult trauma service with rib fractures. The effectiveness of CINB as adjunctive treatment will be compared to standard medical therapy involving nonsteroidal and intravenous/oral opioid medications.

Eligibility Criteria

Inclusion Criteria:Subjects will be at least 18 years oldSubjects will have 2 or more identified rib fracturesSubjects will be willing to provide informed consent for procedureSubjects will be identified as appropriate for initiation of continuous nerve block therapy for treatment of rib fracture associated pain.Exclusion Criteria:Documented allergy to study medicationEpidural catheter usePrisonersRefusal of CINB therapy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05642026). StuddyBuddy aggregates publicly available trial information.